HemaClear® To Present at Summit Medical Group Surgeon Event Dedicated to Sterile, Disposable Tourniquet Technology

Share Article

Prof. Noam Gavriely, MD. DCs, Will Present Clinical Applications

HemaClear®, the world leader in sterile, disposable tourniquet technology, announced today that it will host the Summit Medical Group Surgeon evening on April, 16 2012. The local exclusive product line distributor will host Hemaclear® Chief Medical Officer, Noam Gavriely, MD., DSc, who will present the company’s proprietary technology and its clinically based benefits at 7:00 pm at the Marriot Hotel, Manchester Airport.

“There is increasing concern among health care professionals regarding the risk introduced by contaminated tourniquets placed close to surgical sites”, said Oren Gavriely, CEO of HemaClear®. “HemaClear’s® large, sterile surgical field reduces this risk dramatically, in addition to improving the quality of exsanguination and shortening application time.”

“We’re excited to host this event”, said Frank Collins, Executive Chairman, Summit Medical Group. “The HemaClear® sterile solution continues to make inroads in orthopaedic theatres nationwide. As the market continues to move away from contaminated reusable tourniquets, HemaClear’s® sterile and clinically superior tourniquets present the perfect replacement”, Collins added.

What: UK surgeon evening - Moving to HemaClear, the original sterile, single use, exsanguinating tourniquet.

Who: Prof. Noam Gavriely, MD., DSc., Chief Medical Officer, HemaClear®.

When: April 16th, 2012 at 7pm. Dinner will follow at 8pm.

Where: The Marriot Hotel, Manchester Airport.

How: To attend please contact Fiona Burrows, Summit Medical Group, at +44 1451 823397

About HemaClear
HemaClear® is the original developer of sterile, disposable tourniquet technology that exsanguinates, occludes, and provides a clear surgical field. The technology not only reduces blood loss, infection, and the volume of ischemic tissue, its simplicity saves as much as fifteen minutes of critical OR set-up time‚ eliminating over 100 separate steps that can add as much as $300 to every procedure.
HemaClear represents the single greatest advance in tourniquet technology since the Esmarch bandage. HemaClear® has been proven successful and medically safe worldwide in over 300,000 surgical cases, both in the OR and in the field.
Founded in 1999, HemaClear is based in Haifa, Israel, with offices in 30 countries covering over 2000 operating rooms. For more information about HemaClear, visit http://www.hemaclear.com, or contact info(at)hemaclear(dot)com.

About Summit Medical Ltd:
With 25 years experience in healthcare, Summit Medical Ltd, founded in 1984, has a strong international reputation, for its innovative design and high quality in-house manufacture of solutions for bone cement mixing devices and autologous blood transfusion. In addition to being a leading manufacturer and supplier of single use medical devices to the global market, Summit Medical is also a key distributor of products in the UK. Its expanding product portfolio includes latest advances in wound drainage from Redax® and Medinorm; plus the HemaClear sterile exsanguinating tourniquet from OHK. For more information about Summit Medical, visit http://www.summit-medical.co.uk or contact info(at)summit-medical(dot)co(dot)il

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Omer Inbar
Hemaclear
972.4.824.2369
Email >